Skip to main content

MHA Statement on the Institute for Clinical and Economic Review’s Final Report on Tardive Dyskinesia

Mental Health America (MHA) congratulates the Institute for Clinical and Economic Review (ICER) on the release of its final report, Vesicular Monoamine Transporter 2 Inhibitors for Tardive Dyskinesia: Effectiveness and Value, and thanks ICER for…Read More

MHA Statement on Revisions to 42 CFR Pt II

Mental Health America (MHA) applauds the Substance Abuse and Mental Health Services Administration (SAMHSA) for updating and considering further revisions to the patient confidentiality rule 42 CFR Pt II in…Read More

10 Songs That Helped People Living in Recovery

By Jennifer Cheang, MHA Digital Marketing Manager

Sometimes we don’t have the right words to communicate…Read More

8 Tips for a Successful Visit to Your Elected Official’s Office

When it comes to advocating for an important issue like mental health, phone calls, faxes, emails and letters are all…Read More